Paragon 28 (FNA) – Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Paragon 28 (NYSE: FNA):

• 4/5/2024 – Paragon 28 had its “overweight” rating reaffirmed by analysts at Stephens. They now have a $18.00 price target on the stock.
• 4/4/2024 – Paragon 28 had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
• 3/28/2024 – Paragon 28 had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.
• 3/27/2024 – Paragon 28 had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $18.00 price target on the stock.
• 3/1/2024 – Paragon 28 had its price target raised by analysts at Needham & Company LLC from $16.00 to $17.00. They now have a “buy” rating on the stock.

Paragon 28 Stock Down 1.8 %

Paragon 28 stock opened at $9.65 on Wednesday. Paragon 28, Inc. has a fifty-two week low of $7.95 and a fifty-two week high of $19.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.30 and a current ratio of 4.21. The firm has a 50 day moving average price of $11.56 and a 200 day moving average price of $11.21. The company has a market capitalization of $800.08 million, a PE ratio of -16.64 and a beta of 1.01.

Paragon 28 (NYSE:FNA) last posted its earnings results on Thursday, February 29th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.09). Paragon 28 had a negative net margin of 22.11% and a negative return on equity of 22.51%. The company had revenue of $60.56 million during the quarter, compared to analyst estimates of $60.73 million. Research analysts expect that Paragon 28, Inc. will post -0.43 earnings per share for the current year.

Insider Buying and Selling at Paragon 28

In other Paragon 28 news, insider Albert Dacosta purchased 28,000 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was bought at an average price of $9.12 per share, with a total value of $255,360.00. Following the transaction, the insider now directly owns 5,339,110 shares of the company’s stock, valued at approximately $48,692,683.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 15.32% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Paragon 28

Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. purchased a new stake in shares of Paragon 28 during the 4th quarter worth $25,000. Tower Research Capital LLC TRC raised its stake in Paragon 28 by 203.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,450 shares of the company’s stock worth $61,000 after acquiring an additional 2,312 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Paragon 28 by 22.9% during the 1st quarter. JPMorgan Chase & Co. now owns 4,252 shares of the company’s stock worth $71,000 after acquiring an additional 793 shares in the last quarter. Quantbot Technologies LP acquired a new stake in Paragon 28 during the 2nd quarter worth $92,000. Finally, Osaic Holdings Inc. raised its stake in Paragon 28 by 90.4% during the 2nd quarter. Osaic Holdings Inc. now owns 6,199 shares of the company’s stock worth $108,000 after acquiring an additional 2,943 shares in the last quarter. 63.57% of the stock is owned by hedge funds and other institutional investors.

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.